---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-207610"
form_type: "8-K"
ticker: "CADL"
cik: "0001841387"
company_name: "Candel Therapeutics, Inc."
filed_at: "2022-08-01T23:59:59+00:00"
generated_at: "2026-06-24T06:38:07.407817+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Candel Therapeutics appoints 3 new directors; 3 resign effective Aug 8, 2022

## Summary
- Renee Gaeta, Gary Nabel, and Joseph Papa join the board, replacing Alan Smith, Shaan Gandhi, and Udi Meirav.
- Gaeta is CFO of Eko Devices; Nabel is CEO of ModeX Therapeutics; Papa is CEO of Bausch + Lomb.
- Resignations were not due to any disagreement with the company on operations, policies, or practices.
- New directors each receive option to purchase 28,480 shares vesting over 3 years and standard cash compensation.

## SEC filing metadata
- accession: 0001193125-22-207610
- form_type: 8-K
- ticker: CADL
- cik: 0001841387
- company_name: Candel Therapeutics, Inc.
- filed_at: 2022-08-01T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/d353433d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-207610
- JSON: https://secwatch.observer/filing/0001193125-22-207610.json
- Plain text: https://secwatch.observer/filing/0001193125-22-207610.txt

## Key facts
- Executive change
  Dr. Gary Nabel was appointed as Director at Candel Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: The Board unanimously appointed Renee Gaeta, Dr. Gary Nabel and Joseph Papa, effective August 8, 2022, to fill the newly created vacancies on the Board resulting from the resignations of Dr. Gandhi, Dr. Meirav and Dr. Smith.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm
- Executive change
  Renee Gaeta was appointed as Director at Candel Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: The Board unanimously appointed Renee Gaeta, Dr. Gary Nabel and Joseph Papa, effective August 8, 2022, to fill the newly created vacancies on the Board resulting from the resignations of Dr. Gandhi, Dr. Meirav and Dr. Smith.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm
- Executive change
  Joseph Papa was appointed as Director at Candel Therapeutics, Inc..
  - Action: appointed
  - Role: Director
  source text: The Board unanimously appointed Renee Gaeta, Dr. Gary Nabel and Joseph Papa, effective August 8, 2022, to fill the newly created vacancies on the Board resulting from the resignations of Dr. Gandhi, Dr. Meirav and Dr. Smith.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm
- Executive change
  Alan E. Smith resigned as Director at Candel Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 26, 2022, Shaan Gandhi, Udi Meirav, and Alan E. Smith resigned as members of the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) effective August 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm
- Executive change
  Shaan Gandhi resigned as Director at Candel Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 26, 2022, Shaan Gandhi, Udi Meirav, and Alan E. Smith resigned as members of the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) effective August 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm
- Executive change
  Udi Meirav resigned as Director at Candel Therapeutics, Inc..
  - Action: resigned
  - Role: Director
  source text: On July 26, 2022, Shaan Gandhi, Udi Meirav, and Alan E. Smith resigned as members of the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) effective August 8, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.